<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Psychol Med</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Psychol Med</journal-id><journal-id journal-id-type="publisher-id">IJPsyM</journal-id><journal-title-group><journal-title>Indian Journal of Psychological Medicine</journal-title></journal-title-group><issn pub-type="ppub">0253-7176</issn><issn pub-type="epub">0975-1564</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29200561</article-id><article-id pub-id-type="pmc">5688892</article-id><article-id pub-id-type="publisher-id">IJPsyM-39-641</article-id><article-id pub-id-type="doi">10.4103/IJPSYM.IJPSYM_73_17</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Efficacy of Adjunctive Single Session Counseling for Medically Unexplained Symptoms: A Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Menon</surname><given-names>Vikas</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Shanmuganathan</surname><given-names>Balasubramanian</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Thamizh</surname><given-names>Jaiganesh Selvapandian</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Arun</surname><given-names>Anand Babu</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Sarkar</surname><given-names>Siddharth</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1">Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India</aff><aff id="aff2"><label>1</label>Department of Psychiatry and National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Vikas Menon, Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Puducherry - 605 006, India. E-mail: <email xlink:href="drvmenon@gmail.com">drvmenon@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2017</year></pub-date><volume>39</volume><issue>5</issue><fpage>641</fpage><lpage>647</lpage><permissions><copyright-statement>Copyright: © 2017 Indian Journal of Psychological Medicine</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="3525" xml_f="3533" txt_i="11" txt_f="19">Context:</offsets></title><p><offsets xml_i="3544" xml_f="3632" txt_i="20" txt_f="108">Medically unexplained symptoms (MUS) are often poorly responsive to standard treatments.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3663" xml_f="3667" txt_i="110" txt_f="114">Aim:</offsets></title><p><offsets xml_i="3678" xml_f="3833" txt_i="115" txt_f="270">The aim of the study is to assess short-term efficacy of adjunctive single session cognitive behavior therapy (CBT)-based counseling for patients with MUS.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3864" xml_f="3883" txt_i="272" txt_f="291">Setting and Design:</offsets></title><p><offsets xml_i="3894" xml_f="3976" txt_i="292" txt_f="374">Randomized controlled trial at a psychosomatic clinic of a tertiary care hospital.</offsets></p></sec><sec id="st4"><title><offsets xml_i="4007" xml_f="4029" txt_i="376" txt_f="398">Materials and Methods:</offsets></title><p><offsets xml_i="4040" xml_f="4144" txt_i="399" txt_f="503">Patients with MUS were randomized to receive either the single session counseling (intervention group) (</offsets><italic><offsets xml_i="4152" xml_f="4153" txt_i="503" txt_f="504">n</offsets></italic><offsets xml_i="4162" xml_f="4221" txt_i="504" txt_f="563"> = 41) or control group which received treatment as usual (</offsets><italic><offsets xml_i="4229" xml_f="4230" txt_i="563" txt_f="564">n</offsets></italic><offsets xml_i="4239" xml_f="4488" txt_i="564" txt_f="813"> = 35). The counseling intervention focused on three areas – cognitive reattribution, shifting focus, and guided muscular relaxation and lasted around 30 min. The two groups were assessed at baseline and after 1 month for change in outcome measures.</offsets></p></sec><sec id="st5"><title><offsets xml_i="4519" xml_f="4545" txt_i="815" txt_f="841">Statistical Analysis Used:</offsets></title><p><offsets xml_i="4556" xml_f="4596" txt_i="842" txt_f="882">Repeated measures analysis of variance. </offsets><italic><offsets xml_i="4604" xml_f="4605" txt_i="882" txt_f="883">P</offsets></italic><offsets xml_i="4614" xml_f="4724" txt_i="883" txt_f="990"> value was adjusted for multiple comparisons using Bonferroni correction and set at &lt;0.01 for significance.</offsets></p></sec><sec id="st6"><title><offsets xml_i="4755" xml_f="4763" txt_i="992" txt_f="1000">Results:</offsets></title><p><offsets xml_i="4774" xml_f="4885" txt_i="1001" txt_f="1112">Both groups did not differ on change in the primary outcome measure: Patient Health Questionnaire – 15 scores (</offsets><italic><offsets xml_i="4893" xml_f="4894" txt_i="1112" txt_f="1113">P</offsets></italic><offsets xml_i="4903" xml_f="5031" txt_i="1113" txt_f="1241"> = 0.055). However, at follow-up, the intervention group showed statistically greater reduction in the number of workdays lost (</offsets><italic><offsets xml_i="5039" xml_f="5040" txt_i="1241" txt_f="1242">P</offsets></italic><offsets xml_i="5049" xml_f="5156" txt_i="1242" txt_f="1349"> = 0.005). Trend level changes were noted for depressive symptom reduction only in the intervention group (</offsets><italic><offsets xml_i="5164" xml_f="5165" txt_i="1349" txt_f="1350">P</offsets></italic><offsets xml_i="5174" xml_f="5184" txt_i="1350" txt_f="1360"> = 0.022).</offsets></p></sec><sec id="st7"><title><offsets xml_i="5215" xml_f="5227" txt_i="1362" txt_f="1374">Conclusions:</offsets></title><p><offsets xml_i="5238" xml_f="5452" txt_i="1375" txt_f="1589">One session CBT-based therapy demonstrates potentially important benefits over standard care among Indian patients with MUS. Further testing in larger samples with longer follow-up periods is therefore recommended.</offsets></p></sec></abstract><kwd-group><title>Key words</title><kwd><italic>Cognitive behavior therapy</italic></kwd><kwd><italic>medically unexplained symptoms</italic></kwd><kwd><italic>psychotherapy</italic></kwd><kwd><italic>somatization disorder</italic></kwd><kwd><italic>somatoform disorder</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title><offsets xml_i="5839" xml_f="5851" txt_i="1598" txt_f="1610">INTRODUCTION</offsets></title><p><offsets xml_i="5862" xml_f="6242" txt_i="1611" txt_f="1991">The management of medically unexplained symptoms (MUS) continues to challenge and confound physicians due to multiple issues. These include the lack of a biological finding in the majority of cases, high rates of latent psychiatric morbidity as well as the reluctance on the part of patients to accept psychiatric referrals, and normalizing explanations offered by the clinician.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="6275" xml_f="6276" txt_i="1991" txt_f="1992">1</offsets></xref><xref rid="ref2" ref-type="bibr"><offsets xml_i="6316" xml_f="6317" txt_i="1992" txt_f="1993">2</offsets></xref><offsets xml_i="6324" xml_f="6611" txt_i="1993" txt_f="2280">] While many of these patients may carry rigid, inflexible attitudes about the nature of their symptoms, it is also true that the majority of sufferers are willing to accept more than one explanation for their symptom, thus presenting significant treatment opportunities for clinicians.[</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="6644" xml_f="6645" txt_i="2280" txt_f="2281">3</offsets></xref><xref rid="ref4" ref-type="bibr"><offsets xml_i="6685" xml_f="6686" txt_i="2281" txt_f="2282">4</offsets></xref><offsets xml_i="6693" xml_f="6694" txt_i="2282" txt_f="2283">]</offsets></p><p><offsets xml_i="6701" xml_f="6887" txt_i="2284" txt_f="2470">Growing evidence suggests that multipronged treatment strategies including assimilation of principles from cognitive behavior therapy (CBT) may yield significant treatment gains in MUS.[</offsets><xref rid="ref5" ref-type="bibr"><offsets xml_i="6920" xml_f="6921" txt_i="2470" txt_f="2471">5</offsets></xref><xref rid="ref6" ref-type="bibr"><offsets xml_i="6961" xml_f="6962" txt_i="2471" txt_f="2472">6</offsets></xref><xref rid="ref7" ref-type="bibr"><offsets xml_i="7002" xml_f="7003" txt_i="2472" txt_f="2473">7</offsets></xref><xref rid="ref8" ref-type="bibr"><offsets xml_i="7043" xml_f="7044" txt_i="2473" txt_f="2474">8</offsets></xref><offsets xml_i="7051" xml_f="7252" txt_i="2474" txt_f="2675">] A 10-session CBT-based model for managing MUS has been proposed for application in liaison psychiatric settings that emphasizes the practical management of symptoms as opposed to causal discussions.[</offsets><xref rid="ref9" ref-type="bibr"><offsets xml_i="7285" xml_f="7286" txt_i="2675" txt_f="2676">9</offsets></xref><offsets xml_i="7293" xml_f="7408" txt_i="2676" txt_f="2791">] Numerous studies, mostly from the west, have shown the value of CBT and reattribution techniques in managing MUS[</offsets><xref rid="ref10" ref-type="bibr"><offsets xml_i="7442" xml_f="7444" txt_i="2791" txt_f="2793">10</offsets></xref><xref rid="ref11" ref-type="bibr"><offsets xml_i="7485" xml_f="7487" txt_i="2793" txt_f="2795">11</offsets></xref><xref rid="ref12" ref-type="bibr"><offsets xml_i="7528" xml_f="7530" txt_i="2795" txt_f="2797">12</offsets></xref><offsets xml_i="7537" xml_f="7685" txt_i="2797" txt_f="2945">] but the optimal duration and components of therapy have varied from setting to setting. In this context, it is important to note that Sumathipala </offsets><italic><offsets xml_i="7693" xml_f="7698" txt_i="2945" txt_f="2950">et al</offsets></italic><offsets xml_i="7707" xml_f="7886" txt_i="2950" txt_f="3129">. have published a negative study carried out in an Asian setting, wherein, the authors found that six sessions of CBT work were no more efficacious than structured care for MUS.[</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="7920" xml_f="7922" txt_i="3129" txt_f="3131">13</offsets></xref><offsets xml_i="7929" xml_f="8179" txt_i="3131" txt_f="3381">] This raises interesting questions on cultural background as a determinant of response to CBT in MUS. Guided muscular relaxation therapies have also been widely studied and found to be effective in a variety of settings and syndromes involving MUS.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="8212" xml_f="8213" txt_i="3381" txt_f="3382">1</offsets></xref><xref rid="ref14" ref-type="bibr"><offsets xml_i="8254" xml_f="8256" txt_i="3382" txt_f="3384">14</offsets></xref><offsets xml_i="8263" xml_f="8446" txt_i="3384" txt_f="3567">] Its positive evidence base, simple yet tangible nature makes it an attractive candidate for inclusion in trials involving behavior modification particularly in low-resource setting.</offsets></p><p><offsets xml_i="8453" xml_f="9135" txt_i="3568" txt_f="4250">Against this background, the present study was designed to test the efficacy of add-on single session counseling (SSC), which combines the principles of CBT with guided muscular relaxation, for Indian patients with MUS as compared to treatment as usual (TAU). Specifically, we tested the hypothesis that the proposed SSC intervention would be efficacious in reducing (i) as primary outcome – somatic symptom severity over the 1-month follow-up period and (ii) as secondary outcomes – anxiety and depressive symptoms, number of workdays lost, and number of hospital visits made during the follow-up period. Comparisons of efficacy were made against a psychoeducational control group.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="9198" xml_f="9219" txt_i="4252" txt_f="4273">MATERIALS AND METHODS</offsets></title><sec id="sec2-1"><title><offsets xml_i="9251" xml_f="9275" txt_i="4274" txt_f="4298">Study design and setting</offsets></title><p><offsets xml_i="9286" xml_f="9908" txt_i="4299" txt_f="4921">This was a randomized controlled trial (RCT) carried out in the specialty psychosomatic outpatient clinic at a Government Medical College located in Puducherry, South India, from June 2015 to June 2016. The clinic team includes a consultant psychiatrist, senior resident (qualified psychiatrist), junior resident (postgraduate trainee), a clinical psychologist, and psychiatric social worker. After detailed evaluation of a case by junior resident and discussion with the consultant, a psychiatric diagnosis is allotted as per International Classification of Diseases-10, clinical descriptions, and diagnostic guidelines.[</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="9942" xml_f="9944" txt_i="4921" txt_f="4923">15</offsets></xref><offsets xml_i="9951" xml_f="10079" txt_i="4923" txt_f="5051">] Subsequently, a detailed management plan is formulated which includes both pharmacological and psychosocial treatment options.</offsets></p></sec><sec id="sec2-2"><title><offsets xml_i="10113" xml_f="10133" txt_i="5053" txt_f="5073">Subjects and methods</offsets></title><p><offsets xml_i="10144" xml_f="10684" txt_i="5074" txt_f="5611">Inclusion criteria for participants in the present study included participants aged 18 years or older, presence of single/multiple physical symptoms for at least 3-month duration, and basic/ordered investigations within normal limits following which the symptoms are deemed to be medically unexplained by the treating physician. Patients not having proper referral letters from physicians were excluded as were those above the age of 65 to avoid spurious cases. Other exclusion criteria included Mini-Mental State Examination score &lt;23,[</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="10718" xml_f="10720" txt_i="5611" txt_f="5613">16</offsets></xref><offsets xml_i="10727" xml_f="11506" txt_i="5613" txt_f="6392">] presence of psychotic symptoms, intellectual/hearing or language impairment, and pregnant women or those who have delivered in the last 1 year. Consecutive patients satisfying these criteria were prospectively screened and randomized into one of the two study arms: SSC intervention arm or TAU control arm. The randomization was done using computer-generated random numbers and allocation concealment using sequentially numbered opaque sealed envelopes. The random number sequence was generated and maintained by one of the investigators (VM) not involved directly in patient recruitment or assignment. A total of 84 participants were assessed for eligibility. Of these, 71 were found to be eligible for recruitment and were randomly assigned to either the intervention group (</offsets><italic><offsets xml_i="11514" xml_f="11515" txt_i="6392" txt_f="6393">n</offsets></italic><offsets xml_i="11524" xml_f="11551" txt_i="6393" txt_f="6420"> = 41) or TAU control arm (</offsets><italic><offsets xml_i="11559" xml_f="11560" txt_i="6420" txt_f="6421">n</offsets></italic><offsets xml_i="11569" xml_f="11577" txt_i="6421" txt_f="6429"> = 35) [</offsets><xref ref-type="fig" rid="F1"><offsets xml_i="11607" xml_f="11615" txt_i="6429" txt_f="6437">Figure 1</offsets></xref><offsets xml_i="11622" xml_f="11755" txt_i="6437" txt_f="6570">]. Study procedures were explained in the local language, and written informed consent was obtained from the consenting participants.</offsets></p><fig id="F1" position="float"><label><offsets xml_i="11796" xml_f="11804" txt_i="6571" txt_f="6579">Figure 1</offsets></label><caption><p><offsets xml_i="11824" xml_f="11858" txt_i="6579" txt_f="6613">CONSORT flow diagram for the trial</offsets></p></caption><graphic xlink:href="IJPsyM-39-641-g001"></graphic></fig></sec><sec id="sec2-3"><title><offsets xml_i="11959" xml_f="11970" txt_i="6615" txt_f="6626">Assessments</offsets></title><p><offsets xml_i="11981" xml_f="12099" txt_i="6627" txt_f="6745">Both groups were assessed twice: at baseline and 1 month following the intervention on the following outcome measures:</offsets></p><sec id="sec3-1"><title><offsets xml_i="12127" xml_f="12150" txt_i="6746" txt_f="6769">Primary outcome measure</offsets></title><p><offsets xml_i="12161" xml_f="12281" txt_i="6770" txt_f="6890">Patient Health Questionnaire (PHQ) – 15: This scale comprises 15 somatic symptoms and is derived from the original PHQ.[</offsets><xref rid="ref17" ref-type="bibr"><offsets xml_i="12315" xml_f="12317" txt_i="6890" txt_f="6892">17</offsets></xref><offsets xml_i="12324" xml_f="12536" txt_i="6892" txt_f="7104">] Each symptom is scored from “0” (not bothered at all) to “2” (bothered a lot). The PHQ-15 scale has been previously found to be a valid and reliable questionnaire to screen and monitor symptom severity in MUS.[</offsets><xref rid="ref18" ref-type="bibr"><offsets xml_i="12570" xml_f="12572" txt_i="7104" txt_f="7106">18</offsets></xref><offsets xml_i="12579" xml_f="12580" txt_i="7106" txt_f="7107">]</offsets></p></sec><sec id="sec3-2"><title><offsets xml_i="12614" xml_f="12640" txt_i="7109" txt_f="7135">Secondary outcome measures</offsets></title><p><offsets xml_i="12651" xml_f="12652" txt_i="7136" txt_f="7137">
</offsets><list list-type="order"><list-item><p><offsets xml_i="12690" xml_f="12886" txt_i="7137" txt_f="7333">Generalized anxiety disorder (GAD) – 7: This is a brief self-report measure used both as a screening tool and severity measure of generalized anxiety symptoms with strong psychometric properties.[</offsets><xref rid="ref19" ref-type="bibr"><offsets xml_i="12920" xml_f="12922" txt_i="7333" txt_f="7335">19</offsets></xref><offsets xml_i="12929" xml_f="13014" txt_i="7335" txt_f="7420">] Prior studies on patients with MUS have used this scale to study clinical outcomes[</offsets><xref rid="ref20" ref-type="bibr"><offsets xml_i="13048" xml_f="13050" txt_i="7420" txt_f="7422">20</offsets></xref><offsets xml_i="13057" xml_f="13058" txt_i="7422" txt_f="7423">]</offsets></p></list-item><list-item><p><offsets xml_i="13088" xml_f="13270" txt_i="7424" txt_f="7606">PHQ – 9: This refers to the 9-item self-administered depression module of the larger PHQ, which in turn is derived from the PRIME-MD scale for assessment of common mental disorders.[</offsets><xref rid="ref21" ref-type="bibr"><offsets xml_i="13304" xml_f="13306" txt_i="7606" txt_f="7608">21</offsets></xref><xref rid="ref22" ref-type="bibr"><offsets xml_i="13347" xml_f="13349" txt_i="7608" txt_f="7610">22</offsets></xref><offsets xml_i="13356" xml_f="13437" txt_i="7610" txt_f="7691">] It is widely used to screen for and monitor depression among patients with MUS[</offsets><xref rid="ref20" ref-type="bibr"><offsets xml_i="13471" xml_f="13473" txt_i="7691" txt_f="7693">20</offsets></xref><offsets xml_i="13480" xml_f="13481" txt_i="7693" txt_f="7694">]</offsets></p></list-item><list-item><p><offsets xml_i="13511" xml_f="13651" txt_i="7695" txt_f="7835">Number of hospital visits in the last month: This was assessed from the patient's self-report and cross-checked with the available informant</offsets></p></list-item><list-item><p><offsets xml_i="13681" xml_f="13825" txt_i="7836" txt_f="7980">Number of workdays lost in the last month: This was also assessed from the patient's self-report and cross-checked with the available informant.</offsets></p></list-item></list><offsets xml_i="13848" xml_f="13849" txt_i="7981" txt_f="7982">
</offsets></p><p><offsets xml_i="13856" xml_f="14224" txt_i="7983" txt_f="8351">Telephonic interviews were used to collect outcomes data in case patients did not present themselves physically at follow-up. A separate investigator (JST) not involved in case recruitment, assignment, or intervention carried out baseline and follow-up assessments. Neither the participants nor study staffs were blinded to intervention/control status of participants.</offsets></p></sec></sec><sec id="sec2-4"><title><offsets xml_i="14264" xml_f="14277" txt_i="8354" txt_f="8367">Interventions</offsets></title><p><offsets xml_i="14288" xml_f="14339" txt_i="8368" txt_f="8419">Participants randomized to the intervention group (</offsets><italic><offsets xml_i="14347" xml_f="14348" txt_i="8419" txt_f="8420">n</offsets></italic><offsets xml_i="14357" xml_f="14478" txt_i="8420" txt_f="8541"> = 41) received the SSC for MUS. The session lasted for about 30 min and the intervention focused on the following areas:</offsets></p><p><offsets xml_i="14485" xml_f="14486" txt_i="8542" txt_f="8543">
</offsets><list list-type="order"><list-item><p><offsets xml_i="14524" xml_f="14809" txt_i="8543" txt_f="8828">Validating the patients' complaints through empathic listening: The patients were allowed to elaborate their complaints. They were encouraged to dwell on its links with stressful life events to emphasize the fluctuating nature of symptoms and role of stress in influencing its severity</offsets></p></list-item><list-item><p><offsets xml_i="14839" xml_f="14987" txt_i="8829" txt_f="8977">Reattribution: Here, patients were encouraged to make the link between physical and psychological symptoms in keeping with the reattribution theory[</offsets><xref rid="ref23" ref-type="bibr"><offsets xml_i="15021" xml_f="15023" txt_i="8977" txt_f="8979">23</offsets></xref><offsets xml_i="15030" xml_f="15031" txt_i="8979" txt_f="8980">]</offsets></p></list-item><list-item><p><offsets xml_i="15061" xml_f="15264" txt_i="8981" txt_f="9184">Emphasize working around rather than working on the symptoms: The patients were told that the aim of therapy was to increase their coping with symptoms and enhance functioning rather than reduce symptoms</offsets></p></list-item><list-item><p><offsets xml_i="15294" xml_f="15373" txt_i="9185" txt_f="9264">Relaxation techniques: This was included due to its wide evidence base in MUS.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="15406" xml_f="15407" txt_i="9264" txt_f="9265">1</offsets></xref><xref rid="ref14" ref-type="bibr"><offsets xml_i="15448" xml_f="15450" txt_i="9265" txt_f="9267">14</offsets></xref><offsets xml_i="15457" xml_f="15707" txt_i="9267" txt_f="9517">] Patients were given verbal instructions on progressive muscular relaxation techniques focusing on affected body parts (e.g., head and neck relaxation for unexplained headache) as a strategy to counter symptoms as and when they become discomforting.</offsets></p></list-item></list><offsets xml_i="15730" xml_f="15731" txt_i="9518" txt_f="9519">
</offsets></p><p><offsets xml_i="15738" xml_f="16420" txt_i="9520" txt_f="10202">The intervention sessions were administered by a single qualified psychiatrist (BS). In addition, both groups received standard care that included appropriate pharmacotherapy for symptoms as indicated. The control group (TAU) received brief psychoeducation that focused on disseminating information about the origins, meaning, impact of symptoms in day-to-day life, and management options. However, the reattribution component and muscle relaxation were not included in the content for control group psychoeducation. The study protocol had prior approval from the Institute Ethics Committee. The trial was registered with the Clinical Trials Registry of India (CTRI/2016/07/007082).</offsets></p></sec><sec id="sec2-5"><title><offsets xml_i="16454" xml_f="16474" txt_i="10204" txt_f="10224">Statistical analysis</offsets></title><p><offsets xml_i="16485" xml_f="16688" txt_i="10225" txt_f="10428">The analysis was carried out using SPSS version 21 (IBM Corp., NY, USA). The baseline characteristics and outcome measure scores between the intervention and control groups were compared using Student's </offsets><italic><offsets xml_i="16696" xml_f="16697" txt_i="10428" txt_f="10429">t</offsets></italic><offsets xml_i="16706" xml_f="17123" txt_i="10429" txt_f="10846">-test or Chi-square test. Repeated measures analysis of variance (RMANOVA) was used to ascertain the significance of the intervention on the change in outcome measures over follow-up. For participants who were lost to follow-up, intention to treat analysis was carried out using last observation carried forward method. To reduce Type I error, Bonferroni correction was applied for multiple pairwise comparisons, and </offsets><italic><offsets xml_i="17131" xml_f="17132" txt_i="10846" txt_f="10847">P</offsets></italic><offsets xml_i="17141" xml_f="17196" txt_i="10847" txt_f="10899"> &lt; 0.01 was considered as statistically significant.</offsets></p></sec></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="17255" xml_f="17262" txt_i="10902" txt_f="10909">RESULTS</offsets></title><p><offsets xml_i="17273" xml_f="17457" txt_i="10910" txt_f="11094">The present analysis was based on 76 patients (41 in intervention group and 35 in control group). The demographic and basic clinical characteristics of cases and controls are shown in </offsets><xref ref-type="table" rid="T1"><offsets xml_i="17489" xml_f="17496" txt_i="11094" txt_f="11101">Table 1</offsets></xref><offsets xml_i="17503" xml_f="17620" txt_i="11101" txt_f="11218">. The intervention (SSC) group had higher number of participants of the female gender as compared to controls (TAU) (</offsets><italic><offsets xml_i="17628" xml_f="17629" txt_i="11218" txt_f="11219">P</offsets></italic><offsets xml_i="17638" xml_f="17850" txt_i="11219" txt_f="11431"> = 0.007). There were no significant differences across the groups with respect to other baseline parameters. The baseline clinical parameters which served as outcome measures also did not differ between groups [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="17882" xml_f="17889" txt_i="11431" txt_f="11438">Table 2</offsets></xref><offsets xml_i="17896" xml_f="17898" txt_i="11438" txt_f="11440">].</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="17946" xml_f="17953" txt_i="11441" txt_f="11448">Table 1</offsets></label><caption><p><offsets xml_i="17973" xml_f="18019" txt_i="11448" txt_f="11494">Baseline characteristics of cases and controls</offsets></p></caption><graphic xlink:href="IJPsyM-39-641-g002"></graphic></table-wrap><table-wrap id="T2" position="float"><label><offsets xml_i="18141" xml_f="18148" txt_i="11495" txt_f="11502">Table 2</offsets></label><caption><p><offsets xml_i="18168" xml_f="18222" txt_i="11502" txt_f="11556">Baseline outcome characteristics of cases and controls</offsets></p></caption><graphic xlink:href="IJPsyM-39-641-g003"></graphic></table-wrap><p><offsets xml_i="18303" xml_f="18384" txt_i="11557" txt_f="11638">The changes from the baseline in the primary and secondary outcomes are shown in </offsets><xref ref-type="table" rid="T3"><offsets xml_i="18416" xml_f="18423" txt_i="11638" txt_f="11645">Table 3</offsets></xref><offsets xml_i="18430" xml_f="18658" txt_i="11645" txt_f="11873">. For the participants who had lost to follow-up, intention to treat analysis was carried out. The intervention and control groups differed on change in PHQ-9 scores and the number of workdays lost in last 1 month from baseline.</offsets></p><table-wrap id="T3" position="float"><label><offsets xml_i="18706" xml_f="18713" txt_i="11874" txt_f="11881">Table 3</offsets></label><caption><p><offsets xml_i="18733" xml_f="18813" txt_i="11881" txt_f="11961">Comparison of intervention and control groups from baseline to 1-month follow-up</offsets></p></caption><graphic xlink:href="IJPsyM-39-641-g004"></graphic></table-wrap><p><offsets xml_i="18894" xml_f="19342" txt_i="11962" txt_f="12410">RMANOVA was used to assess the significance of the change in the outcome variables in the pre-post design, with group (intervention versus control) and gender as between-group factors and pre-post assessments as the within-group variable. Gender was used as a factor as it differed between the intervention and control group at baseline. For PHQ-15, time (i.e., follow-up) was not associated with significant decrease in the scores (Pillai's Trace </offsets><italic><offsets xml_i="19350" xml_f="19351" txt_i="12410" txt_f="12411">F</offsets></italic><offsets xml_i="19360" xml_f="19370" txt_i="12411" txt_f="12421"> = 3.811, </offsets><italic><offsets xml_i="19378" xml_f="19379" txt_i="12421" txt_f="12422">P</offsets></italic><offsets xml_i="19388" xml_f="19410" txt_i="12422" txt_f="12444"> = 0.055 and partial η</offsets><sup><offsets xml_i="19415" xml_f="19416" txt_i="12444" txt_f="12445">2</offsets></sup><offsets xml_i="19422" xml_f="19507" txt_i="12445" txt_f="12530"> = 0.054). Group allocation or gender also did not significantly affect the findings.</offsets></p><p><offsets xml_i="19514" xml_f="19600" txt_i="12531" txt_f="12617">Regarding secondary outcomes, the scores on GAD-7 decreased with time (Pillai's Trace </offsets><italic><offsets xml_i="19608" xml_f="19609" txt_i="12617" txt_f="12618">F</offsets></italic><offsets xml_i="19618" xml_f="19628" txt_i="12618" txt_f="12628"> = 8.713, </offsets><italic><offsets xml_i="19636" xml_f="19637" txt_i="12628" txt_f="12629">P</offsets></italic><offsets xml_i="19646" xml_f="19668" txt_i="12629" txt_f="12651"> = 0.004 and partial η</offsets><sup><offsets xml_i="19673" xml_f="19674" txt_i="12651" txt_f="12652">2</offsets></sup><offsets xml_i="19680" xml_f="19874" txt_i="12652" txt_f="12846"> = 0.115), but group membership (intervention versus control) or gender did not have a moderating influence on the outcome. The scores on PHQ-9 significantly decreased with time (Pillai's Trace </offsets><italic><offsets xml_i="19882" xml_f="19883" txt_i="12846" txt_f="12847">F</offsets></italic><offsets xml_i="19892" xml_f="19902" txt_i="12847" txt_f="12857"> = 9.512, </offsets><italic><offsets xml_i="19910" xml_f="19911" txt_i="12857" txt_f="12858">P</offsets></italic><offsets xml_i="19920" xml_f="19942" txt_i="12858" txt_f="12880"> = 0.003 and partial η</offsets><sup><offsets xml_i="19947" xml_f="19948" txt_i="12880" txt_f="12881">2</offsets></sup><offsets xml_i="19954" xml_f="20118" txt_i="12881" txt_f="13045"> = 0.124). The time X group interaction suggested a trend level significance with the reduction in scores more pronounced in the intervention group (Pillai's Trace </offsets><italic><offsets xml_i="20126" xml_f="20127" txt_i="13045" txt_f="13046">F</offsets></italic><offsets xml_i="20136" xml_f="20146" txt_i="13046" txt_f="13056"> = 5.530, </offsets><italic><offsets xml_i="20154" xml_f="20155" txt_i="13056" txt_f="13057">P</offsets></italic><offsets xml_i="20164" xml_f="20186" txt_i="13057" txt_f="13079"> = 0.022 and partial η</offsets><sup><offsets xml_i="20191" xml_f="20192" txt_i="13079" txt_f="13080">2</offsets></sup><offsets xml_i="20198" xml_f="20320" txt_i="13080" txt_f="13202"> = 0.076). Further, only time had a significant effect on the number of visits to the hospital in a month (Pillai's Trace </offsets><italic><offsets xml_i="20328" xml_f="20329" txt_i="13202" txt_f="13203">F</offsets></italic><offsets xml_i="20338" xml_f="20349" txt_i="13203" txt_f="13214"> = 22.949, </offsets><italic><offsets xml_i="20357" xml_f="20358" txt_i="13214" txt_f="13215">P</offsets></italic><offsets xml_i="20367" xml_f="20392" txt_i="13215" txt_f="13237"> &lt; 0.001 and partial η</offsets><sup><offsets xml_i="20397" xml_f="20398" txt_i="13237" txt_f="13238">2</offsets></sup><offsets xml_i="20404" xml_f="20548" txt_i="13238" txt_f="13382"> = 0.255), suggesting that the number of visits decreased in both groups. For the number of workdays lost in a month, both time (Pillai's Trace </offsets><italic><offsets xml_i="20556" xml_f="20557" txt_i="13382" txt_f="13383">F</offsets></italic><offsets xml_i="20566" xml_f="20577" txt_i="13383" txt_f="13394"> = 19.684, </offsets><italic><offsets xml_i="20585" xml_f="20586" txt_i="13394" txt_f="13395">P</offsets></italic><offsets xml_i="20595" xml_f="20620" txt_i="13395" txt_f="13417"> &lt; 0.001 and partial η</offsets><sup><offsets xml_i="20625" xml_f="20626" txt_i="13417" txt_f="13418">2</offsets></sup><offsets xml_i="20632" xml_f="20704" txt_i="13418" txt_f="13490"> = 0.230) and time X group interaction were significant (Pillai's Trace </offsets><italic><offsets xml_i="20712" xml_f="20713" txt_i="13490" txt_f="13491">F</offsets></italic><offsets xml_i="20722" xml_f="20732" txt_i="13491" txt_f="13501"> = 8.281, </offsets><italic><offsets xml_i="20740" xml_f="20741" txt_i="13501" txt_f="13502">P</offsets></italic><offsets xml_i="20750" xml_f="20772" txt_i="13502" txt_f="13524"> = 0.005 and partial η</offsets><sup><offsets xml_i="20777" xml_f="20778" txt_i="13524" txt_f="13525">2</offsets></sup><offsets xml_i="20784" xml_f="20927" txt_i="13525" txt_f="13668"> = 0.111). This suggested that the number of workdays lost decreased in both groups, and the decrease was more in the intervention (SSC) group.</offsets></p></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="20983" xml_f="20993" txt_i="13670" txt_f="13680">DISCUSSION</offsets></title><p><offsets xml_i="21004" xml_f="21334" txt_i="13681" txt_f="14011">The present study shows that a single session of structured counseling for MUS is no more efficacious than routine care in the short-term for control of somatic symptoms and associated anxiety but may improve work productivity and depressive symptoms. Therefore, this intervention may hold some promise in Indian settings. Martin </offsets><italic><offsets xml_i="21342" xml_f="21347" txt_i="14011" txt_f="14016">et al</offsets></italic><offsets xml_i="21356" xml_f="21359" txt_i="14016" txt_f="14019">.,[</offsets><xref rid="ref24" ref-type="bibr"><offsets xml_i="21393" xml_f="21395" txt_i="14019" txt_f="14021">24</offsets></xref><offsets xml_i="21402" xml_f="21843" txt_i="14021" txt_f="14462">] in a methodologically similar study, evaluated the efficacy of an SSC on MUS and found that both the intervention and waitlisted control groups had comparable improvement over 6 months on an array of healthcare utilization parameters, somatization severity, and absenteeism from work. Nonsuperiority of cognitive behavioral intervention delivered by family physician was also noted by investigators studying MUS in a primary care setting.[</offsets><xref rid="ref25" ref-type="bibr"><offsets xml_i="21877" xml_f="21879" txt_i="14462" txt_f="14464">25</offsets></xref><offsets xml_i="21886" xml_f="21887" txt_i="14464" txt_f="14465">]</offsets></p><p><offsets xml_i="21894" xml_f="22158" txt_i="14466" txt_f="14730">In an RCT from Sri Lanka, wherein the investigators compared the efficacy of six sessions of CBT versus structured care consisting of six 30 min sessions with the primary health-care provider, it was observed that CBT was no more efficacious than structured care.[</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="22192" xml_f="22194" txt_i="14730" txt_f="14732">13</offsets></xref><offsets xml_i="22201" xml_f="22327" txt_i="14732" txt_f="14858">] However, a pilot study conducted on a smaller sample showed a superiority of psychiatrist-delivered CBT over standard care.[</offsets><xref rid="ref26" ref-type="bibr"><offsets xml_i="22361" xml_f="22363" txt_i="14858" txt_f="14860">26</offsets></xref><offsets xml_i="22370" xml_f="22596" txt_i="14860" txt_f="15086">] These two studies are particularly relevant for discussion as they are from culturally similar and geographically proximate backgrounds. Our study provides two important methodological advances over the study by Sumathipala </offsets><italic><offsets xml_i="22604" xml_f="22609" txt_i="15086" txt_f="15091">et al</offsets></italic><offsets xml_i="22618" xml_f="22620" txt_i="15091" txt_f="15093">.[</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="22654" xml_f="22656" txt_i="15093" txt_f="15095">13</offsets></xref><offsets xml_i="22663" xml_f="22960" txt_i="15095" txt_f="15392">] first, all the intervention sessions were administered by a single trained psychiatrist who eliminates potential therapist bias and suggests greater fidelity to protocol; and second, our study had a TAU arm which allowed meaningful comparisons of the experimental intervention with routine care.</offsets></p><p><offsets xml_i="22967" xml_f="23305" txt_i="15393" txt_f="15731">The findings of the present intervention in terms of its positive effects on work absenteeism do assume significance. Multiple Indian and foreign studies have highlighted the loss of productivity and economic impact of MUS on its sufferers and emphasized the need for CBT-based interventions in reducing personal distress and disability.[</offsets><xref rid="ref27" ref-type="bibr"><offsets xml_i="23339" xml_f="23341" txt_i="15731" txt_f="15733">27</offsets></xref><xref rid="ref28" ref-type="bibr"><offsets xml_i="23382" xml_f="23384" txt_i="15733" txt_f="15735">28</offsets></xref><xref rid="ref29" ref-type="bibr"><offsets xml_i="23425" xml_f="23427" txt_i="15735" txt_f="15737">29</offsets></xref><offsets xml_i="23434" xml_f="23671" txt_i="15737" txt_f="15974">] Being able to work, even in a somewhat mitigated manner, may reduce guilt feelings of not being able to contribute which will disrupt the cycle of passivity, social isolation, and eventual marginalization seen among patients with MUS.[</offsets><xref rid="ref30" ref-type="bibr"><offsets xml_i="23705" xml_f="23707" txt_i="15974" txt_f="15976">30</offsets></xref><xref rid="ref31" ref-type="bibr"><offsets xml_i="23748" xml_f="23750" txt_i="15976" txt_f="15978">31</offsets></xref><offsets xml_i="23757" xml_f="24308" txt_i="15978" txt_f="16529">] To this extent, the single session intervention described here merits further evaluation. It can also be delivered even in low-resource settings by personnel with minimal training. No previous study has evaluated the feasibility and efficacy of brief CBT-based treatments in MUS in our setting, and therefore, our findings may serve to catalyze further research along similar lines with longer follow-up periods. Encouragingly, the intervention was overall well received as evidenced by the acceptable dropout rate in the intervention group (17.1%).</offsets></p><p><offsets xml_i="24315" xml_f="25056" txt_i="16530" txt_f="17271">The limitations of the study include sampling from a single tertiary care center, short follow-up period, and reliance on patients' self-report for some of the outcome measures such as number of hospital visits in follow-up though we also verified information from the key informant wherever available to minimize recall bias. We also used a strict definition of caseness in MUS which may mean that more cases with greater disability got included. We insisted on a proper referral letter from the physician to minimize errors in recruitment. The strengths of the study include acceptable attrition rates, randomized controlled design, use of prospective assessment, single therapist-delivered intervention, and use of blinded outcome raters.</offsets></p></sec><sec sec-type="conclusions" id="sec1-5"><title><offsets xml_i="25113" xml_f="25124" txt_i="17273" txt_f="17284">CONCLUSIONS</offsets></title><p><offsets xml_i="25135" xml_f="25672" txt_i="17285" txt_f="17822">Single session counseling based on principles of Cognitive-Behavior Therapy may hold significant promise for Indian patients with medically unexplained symptoms (MUS), especially with regard to increasing work productivity and reducing psychological distress. MUS are a complex, multifaceted condition with impairment in various domains, and it may be too simplistic to expect a single session of CBT to exert immediate therapeutic gains. However, it may also not be prudent to write off CBT given its considerable evidence base in MUS.[</offsets><xref rid="ref32" ref-type="bibr"><offsets xml_i="25706" xml_f="25708" txt_i="17822" txt_f="17824">32</offsets></xref><xref rid="ref33" ref-type="bibr"><offsets xml_i="25749" xml_f="25751" txt_i="17824" txt_f="17826">33</offsets></xref><offsets xml_i="25758" xml_f="26079" txt_i="17826" txt_f="18147">] In the present study, we have used simple, easy to deliver techniques, and therefore, we suggest that this model be evaluated in multiple settings and over longer follow-up periods. Future research should also focus on effective therapies for sufferers from MUS who may be unwilling to go through the grind of CBT work.</offsets></p><sec id="sec2-6"><title><offsets xml_i="26107" xml_f="26140" txt_i="18148" txt_f="18181">Financial support and sponsorship</offsets></title><p><offsets xml_i="26151" xml_f="26155" txt_i="18182" txt_f="18186">Nil.</offsets></p></sec><sec id="sec2-7" sec-type="COI-statement"><title><offsets xml_i="26214" xml_f="26235" txt_i="18188" txt_f="18209">Conflicts of interest</offsets></title><p><offsets xml_i="26246" xml_f="26281" txt_i="18210" txt_f="18245">There are no conflicts of interest.</offsets></p></sec></sec></body><back><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>TM</given-names></name><name><surname>Stern</surname><given-names>A</given-names></name><name><surname>Clarke</surname><given-names>DD</given-names></name><name><surname>Ivbijaro</surname><given-names>G</given-names></name><name><surname>Kasney</surname><given-names>LM</given-names></name></person-group><article-title>The treatment of patients with medically unexplained symptoms in primary care: A review of the literature</article-title><source>Ment Health Fam Med</source><year>2010</year><volume>7</volume><fpage>209</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">22477945</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>RC</given-names></name><name><surname>Lein</surname><given-names>C</given-names></name><name><surname>Collins</surname><given-names>C</given-names></name><name><surname>Lyles</surname><given-names>JS</given-names></name><name><surname>Given</surname><given-names>B</given-names></name><name><surname>Dwamena</surname><given-names>FC</given-names></name><etal></etal></person-group><article-title>Treating patients with medically unexplained symptoms in primary care</article-title><source>J Gen Intern Med</source><year>2003</year><volume>18</volume><fpage>478</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">12823656</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rief</surname><given-names>W</given-names></name><name><surname>Broadbent</surname><given-names>E</given-names></name></person-group><article-title>Explaining medically unexplained symptoms-models and mechanisms</article-title><source>Clin Psychol Rev</source><year>2007</year><volume>27</volume><fpage>821</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">17716793</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ravenzwaaij</surname><given-names>J</given-names></name><name><surname>Olde Hartman</surname><given-names>T</given-names></name><name><surname>van Ravesteijn</surname><given-names>H</given-names></name><name><surname>Eveleigh</surname><given-names>R</given-names></name><name><surname>van Rijswijk</surname><given-names>E</given-names></name><name><surname>Lucassen</surname><given-names>P</given-names></name></person-group><article-title>Explanatory models of medically unexplained symptoms: A qualitative analysis of the literature</article-title><source>Ment Health Fam Med</source><year>2010</year><volume>7</volume><fpage>223</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">22477946</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanchard</surname><given-names>EB</given-names></name><name><surname>Scharff</surname><given-names>L</given-names></name></person-group><article-title>Psychosocial aspects of assessment and treatment of irritable bowel syndrome in adults and recurrent abdominal pain in children</article-title><source>J Consult Clin Psychol</source><year>2002</year><volume>70</volume><fpage>725</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">12090379</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>RC</given-names></name><name><surname>Lyles</surname><given-names>JS</given-names></name><name><surname>Gardiner</surname><given-names>JC</given-names></name><name><surname>Sirbu</surname><given-names>C</given-names></name><name><surname>Hodges</surname><given-names>A</given-names></name><name><surname>Collins</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Primary care clinicians treat patients with medically unexplained symptoms: A randomized controlled trial</article-title><source>J Gen Intern Med</source><year>2006</year><volume>21</volume><fpage>671</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16808764</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumathipala</surname><given-names>A</given-names></name></person-group><article-title>What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies</article-title><source>Psychosom Med</source><year>2007</year><volume>69</volume><fpage>889</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">18040100</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witthöft</surname><given-names>M</given-names></name><name><surname>Hiller</surname><given-names>W</given-names></name></person-group><article-title>Psychological approaches to origins and treatments of somatoform disorders</article-title><source>Annu Rev Clin Psychol</source><year>2010</year><volume>6</volume><fpage>257</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">20192784</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>C</given-names></name><name><surname>McMillan</surname><given-names>G</given-names></name></person-group><article-title>A CBT-based approach to medically unexplained symptoms</article-title><source>Adv Psychiatr Treat</source><year>2009</year><volume>15</volume><fpage>146</fpage><lpage>51</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname></surname><given-names>G</given-names></name><name><surname>Timmer</surname><given-names>B</given-names></name><name><surname>Rief</surname><given-names>W</given-names></name></person-group><article-title>Cognitive-behavioural therapy for patients with multiple somatoform symptoms – A randomised controlled trial in tertiary care</article-title><source>J Psychosom Res</source><year>2004</year><volume>56</volume><fpage>449</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">15094031</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larisch</surname><given-names>A</given-names></name><name><surname>Schweickhardt</surname><given-names>A</given-names></name><name><surname>Wirsching</surname><given-names>M</given-names></name><name><surname>Fritzsche</surname><given-names>K</given-names></name></person-group><article-title>Psychosocial interventions for somatizing patients by the general practitioner: A randomized controlled trial</article-title><source>J Psychosom Res</source><year>2004</year><volume>57</volume><fpage>507</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">15596155</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Looper</surname><given-names>KJ</given-names></name><name><surname>Kirmayer</surname><given-names>LJ</given-names></name></person-group><article-title>Behavioral medicine approaches to somatoform disorders</article-title><source>J Consult Clin Psychol</source><year>2002</year><volume>70</volume><fpage>810</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">12090385</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumathipala</surname><given-names>A</given-names></name><name><surname>Siribaddana</surname><given-names>S</given-names></name><name><surname>Abeysingha</surname><given-names>MR</given-names></name><name><surname>De Silva</surname><given-names>P</given-names></name><name><surname>Dewey</surname><given-names>M</given-names></name><name><surname>Prince</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Cognitive-behavioural therapy v. structured care for medically unexplained symptoms: Randomised controlled trial</article-title><source>Br J Psychiatry</source><year>2008</year><volume>193</volume><fpage>51</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18700219</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahmann</surname><given-names>C</given-names></name><name><surname>Röhricht</surname><given-names>F</given-names></name><name><surname>Sauer</surname><given-names>N</given-names></name><name><surname>Noll-Hussong</surname><given-names>M</given-names></name><name><surname>Ronel</surname><given-names>J</given-names></name><name><surname>Henrich</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Functional relaxation as complementary therapy in irritable bowel syndrome: A randomized, controlled clinical trial</article-title><source>J Altern Complement Med</source><year>2010</year><volume>16</volume><fpage>47</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">20064018</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="book"><collab>World Health Organization</collab><source>The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines</source><year>1992</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folstein</surname><given-names>MF</given-names></name><name><surname>Folstein</surname><given-names>SE</given-names></name><name><surname>McHugh</surname><given-names>PR</given-names></name></person-group><article-title>“Mini-mental state”.A practical method for grading the cognitive state of patients for the clinician</article-title><source>J Psychiatr Res</source><year>1975</year><volume>12</volume><fpage>189</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">1202204</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name></person-group><article-title>The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms</article-title><source>Psychosom Med</source><year>2002</year><volume>64</volume><fpage>258</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">11914441</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ravesteijn</surname><given-names>H</given-names></name><name><surname>Wittkampf</surname><given-names>K</given-names></name><name><surname>Lucassen</surname><given-names>P</given-names></name><name><surname>van de Lisdonk</surname><given-names>E</given-names></name><name><surname>van den Hoogen</surname><given-names>H</given-names></name><name><surname>van Weert</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Detecting somatoform disorders in primary care with the PHQ-15</article-title><source>Ann Fam Med</source><year>2009</year><volume>7</volume><fpage>232</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">19433840</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Löwe</surname><given-names>B</given-names></name></person-group><article-title>A brief measure for assessing generalized anxiety disorder: The GAD-7</article-title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><fpage>1092</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16717171</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>C</given-names></name><name><surname>Weller</surname><given-names>D</given-names></name><name><surname>Marsden</surname><given-names>W</given-names></name><name><surname>Worth</surname><given-names>A</given-names></name><name><surname>Sharpe</surname><given-names>M</given-names></name></person-group><article-title>A primary care symptoms clinic for patients with medically unexplained symptoms: Pilot randomised trial</article-title><source>BMJ Open</source><year>2012</year><volume>2</volume><fpage>e000513</fpage></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name></person-group><article-title>The PHQ-9: Validity of a brief depression severity measure</article-title><source>J Gen Intern Med</source><year>2001</year><volume>16</volume><fpage>606</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">11556941</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name></person-group><article-title>Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire</article-title><source>JAMA</source><year>1999</year><volume>282</volume><fpage>1737</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">10568646</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>D</given-names></name><name><surname>Gask</surname><given-names>L</given-names></name><name><surname>O'Dowd</surname><given-names>T</given-names></name></person-group><article-title>The treatment of somatization: Teaching techniques of reattribution</article-title><source>J Psychosom Res</source><year>1989</year><volume>33</volume><fpage>689</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">2621672</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Rauh</surname><given-names>E</given-names></name><name><surname>Fichter</surname><given-names>M</given-names></name><name><surname>Rief</surname><given-names>W</given-names></name></person-group><article-title>A one-session treatment for patients suffering from medically unexplained symptoms in primary care: A randomized clinical trial</article-title><source>Psychosomatics</source><year>2007</year><volume>48</volume><fpage>294</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">17600165</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>IA</given-names></name><name><surname>de Waal</surname><given-names>MW</given-names></name><name><surname>Eekhof</surname><given-names>JA</given-names></name><name><surname>Assendelft</surname><given-names>WJ</given-names></name><name><surname>Spinhoven</surname><given-names>P</given-names></name><name><surname>van Hemert</surname><given-names>AM</given-names></name></person-group><article-title>Medically unexplained physical symptoms in primary care: A controlled study on the effectiveness of cognitive-behavioral treatment by the family physician</article-title><source>Psychosomatics</source><year>2009</year><volume>50</volume><fpage>515</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">19855038</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumathipala</surname><given-names>A</given-names></name><name><surname>Hewege</surname><given-names>S</given-names></name><name><surname>Hanwella</surname><given-names>R</given-names></name><name><surname>Mann</surname><given-names>AH</given-names></name></person-group><article-title>Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: A feasibility study in Sri Lanka</article-title><source>Psychol Med</source><year>2000</year><volume>30</volume><fpage>747</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">11037083</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiller</surname><given-names>W</given-names></name><name><surname>Fichter</surname><given-names>MM</given-names></name><name><surname>Rief</surname><given-names>W</given-names></name></person-group><article-title>A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness</article-title><source>J Psychosom Res</source><year>2003</year><volume>54</volume><fpage>369</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">12670616</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koola</surname><given-names>MM</given-names></name><name><surname>Kuttichira</surname><given-names>P</given-names></name></person-group><article-title>Psychosocioeconomic study of medically unexplained physical symptoms</article-title><source>Indian J Psychol Med</source><year>2012</year><volume>34</volume><fpage>159</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">23162193</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loengaard</surname><given-names>K</given-names></name><name><surname>Bjorner</surname><given-names>JB</given-names></name><name><surname>Fink</surname><given-names>PK</given-names></name><name><surname>Burr</surname><given-names>H</given-names></name><name><surname>Rugulies</surname><given-names>R</given-names></name></person-group><article-title>Medically unexplained symptoms and the risk of loss of labor market participation – A prospective study in the Danish population</article-title><source>BMC Public Health</source><year>2015</year><volume>15</volume><fpage>844</fpage><pub-id pub-id-type="pmid">26329362</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aamland</surname><given-names>A</given-names></name><name><surname>Malterud</surname><given-names>K</given-names></name><name><surname>Werner</surname><given-names>EL</given-names></name></person-group><article-title>Phenomena associated with sick leave among primary care patients with medically unexplained physical symptoms: A systematic review</article-title><source>Scand J Prim Health Care</source><year>2012</year><volume>30</volume><fpage>147</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">22817103</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floderus</surname><given-names>B</given-names></name><name><surname>Göransson</surname><given-names>S</given-names></name><name><surname>Alexanderson</surname><given-names>K</given-names></name><name><surname>Aronsson</surname><given-names>G</given-names></name></person-group><article-title>Self-estimated life situation in patients on long-term sick leave</article-title><source>J Rehabil Med</source><year>2005</year><volume>37</volume><fpage>291</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16203618</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Swindle</surname><given-names>R</given-names></name></person-group><article-title>Cognitive-behavioral therapy for somatization and symptom syndromes: A critical review of controlled clinical trials</article-title><source>Psychother Psychosom</source><year>2000</year><volume>69</volume><fpage>205</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">10867588</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raine</surname><given-names>R</given-names></name><name><surname>Haines</surname><given-names>A</given-names></name><name><surname>Sensky</surname><given-names>T</given-names></name><name><surname>Hutchings</surname><given-names>A</given-names></name><name><surname>Larkin</surname><given-names>K</given-names></name><name><surname>Black</surname><given-names>N</given-names></name></person-group><article-title>Systematic review of mental health interventions for patients with common somatic symptoms: Can research evidence from secondary care be extrapolated to primary care?</article-title><source>BMJ</source><year>2002</year><volume>325</volume><fpage>1082</fpage><pub-id pub-id-type="pmid">12424170</pub-id></element-citation></ref></ref-list></back></article>